|
[1] Seeff LB. Natural history of hepatitis C[J].Hepatology, 1997, 26 (Suppl) ∶21-28.
|
|
[2]Sobue S, Nomura T, Ish ikawa T, et al.Th1/Th2 cytok ine profilesand their relationsh ip to clin ical features in patientsw ith chron ic hep-atitis C virus infection[J].J Gastroenterol, 2001, 36 (8) ∶544-551.
|
|
[3] Napoli J, B ishop GA, M cGu inness PH, et al.Prog-ressive liver in-jury in chron ic hepatitis C infection correlates w ith increased intrahe-patic expression of Th1-associated cytok ines[J].Hepatology, 1996, 24 (4) ∶759-765.
|
|
[4] Lechmann M, Woita P, Langhans B, et al. De-creased frequency of HCV core-specific peripheral blood mononuclear cells with type 1 cytokine se-cretion in chronic hepatitis C[J].J Hepatol, 1999, 31 (6) ∶971-978.
|
|
[5] Jia HY, Du J, Zhu SH, et al. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C[J].Hepatobiliary Pancreat Dis Int, 2002, 1 (3) ∶378-382.
|
|
[6] Grungreiff K, Reinhold D, Ansorge S. Serum concentrations of sIL-2R, IL-6, TGF-betal, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha[J].Cytokine, 1999, 11 (12) ∶1076-1080.
|
|
[7] Yao HP, X ia D J, Zhang LH, et al.Serum levels of sFas, sICAM-1, IL-18 in patients w ith chron ic hepatitis C and their clin ical sig-n ificance[J].Zhejiang Da Xue Xue Bao Y i Xue Ban, 2002, 31 (1) ∶2-5.
|
|
[8] Ha SJ, K im D J, Baek KH, et al.IL-23 induces stronger sustainedCTL and Th1 immune responses than IL-12 in hepatitis C virus en-velope protein 2 DNA immun ization[J].J Immunol, 2004, 172 (1) ∶525-531.
|
|
[9] Kaneko T, Nakaura I, Kita H, et al. Three new cytotoxic T cell epitopes identified with in the hepatitis C virus nucleo protein[J].J Gen Virol, 1996, 77 (6) ∶1305-1309.
|
|
[10] Wang H, Eckels DD. Mutations in immunodominant T cell epitopes derived from the non-structural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition[J].J Immunol, 1999, 162 (7) ∶4177-4183.
|
|
[11] Eckels DD, Tabatabail N, Bian TH, et al. In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite prolife-ration[J].Hum Immunol. 1999, 60 (3) ∶187-199.
|
|
[12] Ch ien DY, Arcangel P, CoitD, et al.Use of an ovel hepatitis C vi-rus (HCV) major-ep itope ch im eric poly peptide for d iagnosis ofHCV infection[J].J C lin M icrob iol, 1999, 37 (5) ∶1393-1397.
|
|
[13]Masak i N, Fukush ima S, Hayash i S.Lower th-1/th-2 ratio be-fore interferon therapy may favor long-term virological responses inpatients w ith chron ic hepatitis C[J].D ig D is Sci, 2002, 47 (10) ∶2163-2169.
|
|
[14] Marinho RT, P into R, SantosML, et al.E ffects of interferon andribavirin comb ination therapy on CD4+proliferation, lymphocyte ac-tivation, and Th1 and Th2 cytok ine profiles in chron ic hepatitis C[J].J V iralHepat, 2004, 11 (3) ∶206-216.
|
|
[15] Andreone P, G ram enzi A, Loggi E, et al.In vitro effect of indom-ethacin and interferon-alpha on Th1 and Th2 cytok ine synthesis inpatients w ith chron ic hepatitis C[J].Cytok ine, 2004, 26 (3) ∶95-101.
|
|
[16]P iazzolla G, Tortorella C, Sch irald i O, et al.Relationsh ip betweenin-terferon-gamma, interleuk in-10, and interleuk in-12 produc-tion in chron ic hepatitis C and invitroeffects of interferon-alpha[J].J C lin Immunol, 2000, 20 (1) ∶54-61.
|
|
[17] Naoumov NV, Rossol S.Stud ies of interleuk in-12 in chron ic hep-atitis B virus infection[J].J V iralHepat, 1997, 4 (supp12) ∶87-91.
|
|
[18] Barth H, Klein R, Berg PA, et al. Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection[J].Hepatogastroenterology, 2003, 50 (49) ∶201-206.
|
|
[19] Teuber G, Rossol S, Lee JH, et al.TH1/TH2 serum cytok ine pro-files and solub le TNF-receptor response in patients w ith chron ichepatitis C during recomb inant human interleuk in-12 (rHuIL-12) treatm ent[J].Z Gastroenterol, 2002, 40 (7) ∶487-495.
|
PDF下载 ( 116 KB)
本文二维码
下载:
